ELIGIBILITY COAPT TRIAL IN DAILY PRACTICE: A REAL WORLD EXPERIENCE
Anno:
2023
Background: The COAPT Trial was the first ever to demonstrate a survival benefit in treating functional mitral regurgitation (FMR). That was achieved through transcatheter mitral repair in selected patient. The exact proportion of patients fulfilling COAPT selection criteria in the real-world is unknown. Objectives: to assess the of COAPT…